| Protocol: | A Randomized Clinical Trial Evaluating Combination Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of Proliferative Diabetic Retinopathy |
| Status: | Recruiting |
| Start Date: | 04/17/2025 |
| End Date: | |
| Clinical Trial ID: | NCT06790784 |
| Public Dataset: |
|